Preclinical blood test could predict severe respiratory conditions

A scientific team supported by the National Institutes of Health (NIH) has created a preclinical blood test to identify adults most likely to develop severe respiratory conditions, including chronic obstructive pulmonary disease (COPD).

Johnson & Johnson acquires Ambrx Biopharma for $2bn

Share this article J&J will gain access to the Ambrx pipeline comprising candidate therapeutics for a range of cancer indications. Credit: Michael Vi / Shutterstock.com.

March 8, 2024

FDA approves GSK’s JAK inhibitor for rare blood cancer after three-month delay

The FDA approved a new JAK inhibitor, momelotinib, from GSK for adults with the rare bone marrow cancer myelofibrosis who also have anemia. The approval

September 16, 2023

Patient symptom information enhances MRI accuracy for lumbar spine diagnosis

Knowing a patient’s symptoms helps radiologists in lumbar spine MRI interpretation and diagnosis, according to a study published today in Radiology, a journal of the

October 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.